FindTrial
Sign In

biological response modifier therapy

PROCEDURE3 trials

Sponsors

Radiation Therapy Oncology Group, National Cancer Institute (NCI), Barbara Ann Karmanos Cancer Institute

Conditions

LeukemiaLymphomaRecurrent Adult Soft Tissue SarcomaStage IIB Adult Soft Tissue SarcomaStage IIC Adult Soft Tissue SarcomaStage III Adult Soft Tissue SarcomaStage IVA Adult Soft Tissue SarcomaUnspecified Adult Solid Tumor, Protocol Specific

Phase 1

Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors
WithdrawnNCT00052403
Barbara Ann Karmanos Cancer InstituteUnspecified Adult Solid Tumor, Protocol Specific
Start: 2002-02-28Updated: 2014-01-16
BL22 Immunotoxin in Treating Patients With Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
WithdrawnNCT00024115
National Cancer Institute (NCI)Leukemia, Lymphoma
Updated: 2015-04-28

Phase 2

Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma
WithdrawnNCT00017160
Radiation Therapy Oncology GroupRecurrent Adult Soft Tissue Sarcoma, Stage IIB Adult Soft Tissue Sarcoma, Stage IIC Adult Soft Tissue Sarcoma +2
Updated: 2013-06-27